AbCellera Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	77.06	128.51	156.33	133.32	386.54	476.14
Short-Term Investments	427.67	405.31	469.29	627.27	499.95	246.84
Cash & Short-Term Investments	504.73	533.83	625.61	760.59	886.49	722.98
Cash Growth	-16.61%	-14.67%	-17.75%	-14.20%	22.62%	21.69%
Accounts Receivable	36.76	58.29	33.62	30.59	38.59	160.58
Other Current Assets	123.1	136.11	92.14	80.81	100.41	46.25
Total Current Assets	664.6	728.23	751.37	871.99	1,025	929.8
Net Property, Plant & Equipment	422.81	428	340.43	287.7	217.26	111.62
Other Intangible Assets	37.46	38.38	42.11	120.43	131.5	148.39
Goodwill	47.81	47.81	47.81	47.81	47.81	47.81
Long-Term Investments	65.31	62.58	82.3	65.94	72.52	50.31
Other Long-Term Assets	69.14	51.95	96.54	94.24	46.33	30.64
Total Assets	1,307	1,357	1,361	1,488	1,541	1,319
Accounts Payable	39.55	50.78	55	49.58	52.5	32.02
Unearned Revenue	7.74	13.53	13.52	18.96	21.61	7.54
Other Current Liabilities	-	-	8.09	50.48	44.21	81.12
Total Current Liabilities	47.29	64.31	76.61	119.01	118.32	120.68
Long-Term Leases	134.31	137.4	60.74	71.22	76.68	36.41
Other Long-Term Liabilities	187.43	188.34	167.11	145.54	112.64	135.75
Total Long-Term Liabilities	321.74	325.74	227.86	216.76	189.31	172.16
Total Liabilities	369.03	390.05	304.47	335.78	307.63	292.84
Common Stock	816.53	802.34	777.17	753.2	734.37	722.43
Additional Paid-in Capital	196.62	198.28	166.36	121.05	74.12	35.36
Accumulated Other Comprehensive Income	-2.42	-4.23	-4.38	-1.72	-1.39	0.28
Retained Earnings	-72.65	-29.48	116.93	279.79	426.19	267.67
Shareholders' Equity	938.08	966.9	1,056	1,152	1,233	1,026
Total Liabilities & Equity	1,307	1,357	1,361	1,488	1,541	1,319
Total Debt	134.31	137.4	60.74	71.22	76.68	36.41
Net Cash (Debt)	370.42	396.42	564.87	689.36	809.81	686.56
Net Cash Growth	-6.56%	-29.82%	-18.06%	-14.87%	17.95%	16.29%
Net Cash Per Share	1.24	1.33	1.92	2.38	2.57	2.16
Book Value	938.08	966.9	1,056	1,152	1,233	1,026
Book Value Per Share	3.13	3.24	3.59	3.98	3.92	3.22
Tangible Book Value	852.82	880.72	966.17	984.09	1,054	829.54
Tangible Book Value Per Share	2.84	2.95	3.28	3.40	3.35	2.61

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q